Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells

Mittal Shah, Asher Maroof, Panos Gikas, Gayatri Mittal, Richard Keen, Dominique Baeten, Stevan Shaw, Scott J. Roberts

RMD Open · 2020 · 53 citations · 21 references

DOIFull text

Open access

Abstract

These data show for the first time that IL-17A and IL-17F enhance in vitro osteogenic differentiation and bone formation from hPDCs, inhibition of which may offer an attractive therapeutic strategy to prevent pathological bone formation.

References

21